No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
123 |
4. Check minimum number of eventsNone |
123 |
5. Include endpointsNone |
123 |
6. Filter based on genotype QC (FinnGen only) |
118 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Interstitial cystitis (chronic), drug-induced
based on the number of shared cases.
Similar with more cases:
- Cystitis
- Other diseases of urinary system
- Genitourinary diseases
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 118 | 105 | 13 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.01 |
| Median age at first event (years) | 50.13 | 49.94 | 51.65 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 120
- Matched controls
- 1200
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
+∞
161.1
120
8
KCV04
NOMESCO Finland
Distension of bladder with fluid
507.6
85.7
76
*
UKC02
NOMESCO Finland
Cystoscopy
31.6
84.5
88
96
G04BD07
ATC
tolterodine; oral
17.5
49.7
50
47
G04BD04
ATC
oxybutynin; oral, transdermal
15.5
49.7
57
66
5951A
ICD-9 Finland
Cystitis, Chronic interstitial cystitis
+∞
34.0
31
*
7325
FHL
Bladder stretching
+∞
31.7
29
*
XKD00
NOMESCO Finland
Uroflowmetry
10.4
30.6
42
59
R35
ICD-10 Finland
Polyuria
8.4
21.4
33
52
59504
ICD-8 Finland
Cystitis, Interstitialis (Hunner)
237.6
20.2
20
*
1530
FHL
Urethrocystoscopy
46.8
19.4
23
6
TKD00
NOMESCO Finland
Dilatation of urethra
111.9
18.1
19
*
N30.0
ICD-10 Finland
Acute cystitis
4.7
15.3
51
162
J01MA06
ATC
norfloxacin; oral
4.8
15.1
49
152
ZX136
NOMESCO Finland
Intravesicalis
91.6
15.0
16
*
J01EA01
ATC
trimethoprim; systemic
4.3
14.2
70
294
N06CA01
ATC
amitriptyline and psycholeptics; systemic
5.4
14.1
34
82
G04BD
ATC
Drugs for urinary frequency and incontinence
157.0
13.8
14
*
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
45.6
13.5
16
*
N30.9
ICD-10 Finland
Cystitis, unspecified
5.4
11.9
27
61
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.7
11.8
25
53
KCV02
NOMESCO Finland
Cystoscopic balloon distension of bladder
+∞
11.6
11
*
L04AA01
ATC
[U] ciclosporin
28.3
11.5
15
6
7321
FHL
TU biopsy, coagulation or laser
+∞
10.6
10
*
J01MA02
ATC
ciprofloxacin; systemic
3.6
10.5
74
373
N02AX02
ATC
tramadol; systemic, rectal
3.5
10.4
75
384
UJF32
NOMESCO Finland
Coloscopy
3.5
10.3
53
219
TKC20
NOMESCO Finland
Catheterisation of bladder
5.5
10.2
22
47
P01BA02
ATC
hydroxychloroquine; oral
4.5
9.7
27
72
G04AC01, ,
ATC
9.0
9.6
20
26
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
9.2
59
276
G04BD01
ATC
emepronium; systemic
20.6
9.2
13
7
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
26.4
9.1
12
5
A03FA02
ATC
cisapride; oral, rectal
4.7
8.8
23
58
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.1
8.8
65
328
J01MA01
ATC
ofloxacin; systemic
4.5
8.7
24
63
R30.0
ICD-10 Finland
Dysuria
8.1
8.7
19
27
N06AA09
ATC
amitriptyline; systemic
4.0
8.2
27
81
R01AD12
ATC
fluticasone furoate; nasal
3.1
8.0
50
226
XKD06
NOMESCO Finland
Physiologic investigation of micturition
9.9
7.8
15
17
R30.1
ICD-10 Finland
Vesical tenesmus
13.1
7.8
13
11
G04BD12
ATC
mirabegron; oral
3.7
7.7
29
96
G44.2
ICD-10 Finland
Tension-type headache
3.6
7.2
28
94
A03CA02
ATC
clidinium and psycholeptics; oral
4.6
7.1
18
44
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.9
6.8
42
187
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
6.8
64
355
J01CA08
ATC
pivmecillinam; oral
2.9
6.5
85
550
G03CA04
ATC
estriol; systemic, vaginal
3.5
6.5
25
83
90621, ,
NOMESCO Finland
73.6
6.5
7
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
12.0
6.4
11
10
G04BD11
ATC
fesoterodine; oral
7.8
6.4
14
20
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.7
6.4
52
266
KCC00
NOMESCO Finland
Cystectomy
+∞
6.3
6
*
7362
FHL
Urethral dilatation in anesthesia or operating room
+∞
6.3
6
*
U07
ICPC
Urine symptom/complaint other
3.6
6.3
23
74
A02BA02
ATC
ranitidine; systemic
2.8
6.2
39
174
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
22
91
2.74
3.91
3.7
2.6
0.21
1.61
e6/l
0.72
22
85
45
265
2.12
3.64
9.4
4.6
1.01
1.02
kg/l
0.69
34
171
9
22
4.33
2.94
2.9
2.8
—
—
—
0
0
37
219
2.00
2.87
6.1
4.3
575.63
163.25
ng/l
0.67
27
183
32
185
2.00
2.63
6.8
3.1
3.55
3.67
e6/l
0.03
20
88
31
178
2.00
2.59
1.9
3.2
0.83
0.80
mmol/l
0.68
31
161
6
11
5.67
2.57
1.7
2.5
—
—
—
0
0
5
7
7.39
2.57
1.4
1.7
—
—
—
0
0
5
7
7.39
2.57
1.4
1.7
—
—
—
0
0
5
7
7.39
2.57
1.4
1.7
—
—
—
0
0
49
329
1.83
2.56
5.9
3.4
0.23
0.50
e6/l
1.15
44
240
15
67
2.42
2.28
6.6
5.5
25.58
24.92
mmol/l
0.34
15
67
61
450
1.72
2.24
7.9
4.6
0.00
0.00
estimate
—
10
103
9
30
3.16
2.20
2.6
1.4
—
—
—
0
0
55
396
1.72
2.19
6.6
3.3
—
—
—
0
0
15
70
2.31
2.08
1.1
1.2
37.64
159.11
u/ml
—
7
30
54
393
1.68
2.03
2.9
2.2
111.90
201.37
u/l
1.12
49
369
76
609
1.68
1.95
8.7
4.5
0.00
0.00
estimate
-0.00
17
121
6
17
3.66
1.86
1.8
1.4
—
—
—
0
0
32
207
1.74
1.82
6.7
3.0
1.70
1.08
e6/l
0.25
21
108
47
343
1.61
1.69
9.6
4.4
0.00
0.00
estimate
-0.00
15
119
10
41
2.57
1.69
1.4
1.3
1.35
1.20
g/l
—
10
41
39
272
1.64
1.68
1.4
1.2
0.56
2.25
u/ml
1.09
11
71
74
603
1.59
1.66
8.6
4.5
0.00
0.00
estimate
-0.00
16
126
21
125
1.82
1.56
2.1
1.7
—
—
—
0
0
74
610
1.56
1.52
8.8
4.5
0.00
0.00
estimate
-0.00
17
131
55
425
1.54
1.51
3.0
3.5
2.39
2.36
mmol/l
0.88
50
390
16
89
1.92
1.45
2.2
3.2
76.33
63.70
ml/min/173m2
—
6
46
9
40
2.35
1.43
1.4
1.3
0.25
0.23
g/l
—
9
40
5
17
3.02
1.37
1.2
1.6
—
—
—
0
0
24
155
1.69
1.36
1.9
1.5
—
—
—
0
0
14
76
1.95
1.36
1.8
2.6
1.24
1.21
%
0.05
14
76
8
35
2.38
1.29
1.0
1.6
—
—
—
0
0
14
79
1.87
1.23
1.4
1.7
—
—
—
0
0
8
38
2.18
1.21
1.1
1.7
2.41
3.12
g/l
—
8
38
13
72
1.90
1.20
7.3
5.9
95.42
94.42
%
0.72
13
72
26
180
1.57
1.13
2.0
1.8
—
—
—
0
0
5
21
2.44
1.10
1.2
1.0
—
—
—
0
0
13
75
1.82
1.08
1.8
2.6
0.53
0.63
%
0.58
13
75
45
354
1.43
1.06
1.6
1.7
21.30
21.91
nmol/l
0.09
38
297
28
201
1.51
1.04
1.3
1.5
—
—
—
0
0
10
54
1.93
1.00
1.8
1.6
4.66
9.07
iu/ml
—
5
15
0
31
0.00
0.98
0.0
1.3
—
333.73
—
0
18
22
152
1.55
0.97
4.9
1.8
29.65
28.98
s
0.14
22
146
6
29
2.12
0.90
1.0
1.8
6.18
6.50
pmol/l
—
6
29
8
42
1.97
0.90
1.1
1.7
3.69
3.79
g/l
—
8
42
8
42
1.97
0.90
1.1
1.7
7.13
7.88
g/l
—
8
42
8
42
1.97
0.90
1.1
1.7
4.34
4.23
g/l
—
8
42
69
597
1.37
0.89
6.3
5.8
1.22
1.22
mmol/l
0.03
61
513
29
217
1.44
0.88
1.6
1.3
16.83
41.16
iu/ml
—
6
76
19
131
1.54
0.85
1.8
1.7
—
—
—
0
0
73
642
1.35
0.83
5.3
4.8
6.53
6.61
mmol/l
0.19
67
599
8
47
1.75
0.82
1.3
1.3
—
—
—
0
0
27
202
1.43
0.82
1.6
1.3
31.96
10.35
u/ml
0.34
12
78
53
445
1.34
0.81
6.9
4.4
33.33
36.14
ng/l
0.08
32
323
13
83
1.64
0.78
1.8
1.3
—
—
—
0
0
19
134
1.50
0.77
6.1
5.3
13.18
11.64
kpa
0.65
19
128
19
134
1.50
0.77
6.1
5.3
5.34
5.17
kpa
0.44
19
128
68
597
1.32
0.75
7.8
9.5
4.07
4.11
e9/l
0.05
62
528
10
60
1.73
0.74
1.4
1.6
—
—
—
0
0
7
39
1.84
0.74
2.4
2.5
—
—
—
0
0
7
40
1.80
0.72
1.1
1.2
—
—
—
0
0
7
40
1.80
0.72
1.1
1.7
—
—
—
0
0
5
26
1.96
0.71
2.2
1.3
—
—
—
0
0
19
137
1.46
0.70
2.8
4.0
1.04
1.09
mmol/l
0.45
19
119
5
29
1.75
0.64
1.2
1.4
—
—
—
0
0
5
29
1.75
0.64
1.2
1.4
—
—
—
0
0
13
90
1.50
0.58
2.9
5.9
9.25
9.43
mmol/l
0.03
13
83
6
36
1.70
0.57
1.0
1.3
—
—
—
0
0
6
38
1.61
0.55
3.8
2.4
—
—
—
0
0
9
62
1.49
0.54
1.9
3.4
24.34
24.97
mmol/l
—
9
62
89
830
1.28
0.52
6.5
4.8
15.03
14.90
pmol/l
0.20
84
745
7
48
1.49
0.48
2.4
2.4
—
—
—
0
0
10
70
1.47
0.43
2.0
3.6
48.35
44.04
%
—
10
70
5
32
1.59
0.43
1.2
1.2
—
—
—
0
0
5
33
1.54
0.42
1.6
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
0.97
—
0
10
0
15
0.00
0.41
0.0
1.7
—
1.04
—
0
10
0
15
0.00
0.41
0.0
1.7
—
1.25
—
0
10
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
40
350
1.21
0.40
2.8
3.7
2.25
6.97
mg/mmol
1.80
28
200
15
118
1.31
0.35
20.7
7.0
—
—
—
0
0
93
969
0.82
0.34
24.8
17.3
76.22
76.18
ml/min/173m2
0.01
88
900
15
119
1.30
0.33
4.1
4.0
—
—
—
0
0
37
327
1.19
0.33
5.4
4.0
0.00
0.01
estimate
—
10
99
23
269
0.82
0.32
2.8
2.6
332.74
328.49
umol/l
0.05
23
234
56
515
1.16
0.31
2.5
2.1
112.09
98.30
pmol/l
0.91
20
248
95
984
0.83
0.28
7.1
6.2
2.61
2.66
mmol/l
0.22
90
906
87
831
1.17
0.28
27.2
21.2
13.76
13.81
%
0.11
87
821
7
93
0.74
0.23
3.4
6.3
2.09
2.71
ug/l
—
7
84
5
42
1.20
0.22
2.2
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
3.25
—
0
12
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
50
1.21
0.20
1.2
1.4
—
—
—
0
0
97
953
1.09
0.09
7.9
6.1
1.77
1.90
mu/l
0.56
91
879
6
57
1.06
0.08
1.3
1.0
—
—
—
0
0
7
68
1.03
0.08
1.9
2.3
—
—
—
0
0
8
75
1.07
0.07
1.9
2.5
—
—
—
0
0
47
485
0.95
0.06
3.0
2.7
—
—
estimate
—
0
0
101
1001
1.06
0.03
24.8
17.5
19.78
22.04
mg/l
0.44
92
822
25
242
1.04
0.02
1.7
1.8
462.65
470.15
pmol/l
0.04
20
197
25
244
1.03
0.00
2.4
2.2
—
—
—
0
0
57
574
0.99
0.00
3.2
2.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1656.50
—
0
6
0
8
0.00
-0.00
0.0
3.9
—
538.13
—
0
8
0
6
0.00
-0.00
0.0
1.5
—
13.00
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
13.62
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
11.22
—
0
6
0
7
0.00
-0.00
0.0
1.9
—
3.21
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.8
—
0.33
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: INTERSTITIAL_CYSTIT_CHRONIC – Interstitial cystitis (chronic), drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).